18.31USD-1.61%Mkt Cap: 806.02M USDP/E: 11.01Last update: 2026-06-01
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. I…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap806.02M USD
Enterprise Value1.23B USD
Revenue (TTM)720.53M USD
Gross Profit356.06M USD
Net Income (TTM)98.09M USD
Revenue/Share15.61 USD
Last Price18.31 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees2.0K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS03209R1032
Valuation
P/E (Trailing)11.01
P/E (Forward)5.75
PEG—
EV/EBITDA6.21
EV/Revenue1.70
P/S1.15
P/B1.09
EPS (TTM)1.66
EPS (Forward)3.28
52W Range
16.6511% of range31.26
52W High31.26 USD
52W Low16.65 USD
Profitability
Gross Margin49.46%
Oper. Margin7.96%
EBITDA Margin27.38%
Profit Margin13.63%
ROE12.44%
ROA6.02%
Growth
Revenue Growth0.40%
Earnings Growth-72.50%
Cash Flow & Leverage
Operating CF156.12M USD
CapEx (TTM)37.13M USD
FCF Margin14.31%
FCF Yield12.79%
Net Debt394.43M USD
Net Debt/EBITDA2.00
Balance Sheet
Debt/Equity0.83
Current Ratio3.85
Quick Ratio2.73
Book Value/Sh17.33 USD
Cash/Share6.621 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)23.33 USD
Target Range19.00 USD – 30.00 USD
# Analysts6
Ownership
Shares Out.44.09M
Float32.84M
Insiders29.63%
Institutions76.36%
Short Interest
Short Ratio6.3d
Short % Float17.94%
Short % Out.8.57%
Shares Short3.78M
Short (prev mo.)3.90M
Technical
SMA 5020.22 (-9.4%)
SMA 20024.84 (-26.3%)
Beta0.97
S&P 52W Chg27.94%
Avg Vol (30d)627.13K
Avg Vol (10d)780.96K
Technical Indicators
RSI (14)43.7
MACD-0.6514
MACD Signal-0.7514
MACD Hist.+0.1000
BB Upper24.13 USD
BB Middle19.45 USD
BB Lower14.77 USD
BB Width48.10%
ATR (14)0.9061 USD
Vol Ratio (20d)0.61x